PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
To assess the blood levels of hypericin and any electrocardiogram (ECG) changes during 8
weeks of HyBryte (topical hypericin ointment) photodynamic therapy.